Hear from experts about the intricacies biotech and medtech startups face when securing Intellectual Property (IP) rights from the USPTO and seeking regulatory approval from the FDA. Government officials and industry professionals will offer their insights and highlight best practices for startups navigating USPTO and FDA procedures.
This event is free and open to the public. Space is limited so register early.
The discussion will cover:
- Navigating the USPTO patent process, with an emphasis on biotech and medtech industries
- Navigating the FDA regulatory process
- Strategies, tips, and best practices to maximize IP protection and exclusivity
12:00 p.m.: Registration
12:00 - 12:30 p.m.: Lunch
12:30 - 12:45 p.m.: Introductory remarks
Director of the Silicon Valley United States Patent and Trademark Office John Cabeca
12:45 - 2:00 p.m.: Navigating through the USPTO
Daniel Sullivan, USPTO – Director, Technology Center 1600 (Biotechnology)
Jerry Lorengo, USPTO – Director, Technology Center 3700 (Medical Devices/Processes)
Chris Walsh, Ph.D., Denali Therapeutics - Vice President, Legal
2:15 - 3:30 p.m.: Navigating through the FDA
FDA Consumer Safety Officer Forest “Ray” Ford, Jr., PharmD
3:45 - 4:45 p.m.: Beyond the FDA + USPTO – Strategic considerations panel
Moderated by Laure Fabrega, Biocom – Director, Federal Policy and Government affairs
Daniel Sullivan, Jerry Lorengo, Chris Walsh, Ray Ford, Jr.,
Cary Miller, Ph.D., Jones Day – Partner
5:00 p.m.: Networking reception
Lunch and networking reception provided courtesy of Jones Day, through Biocom.